Series C transaction led by B Capital with participation from Decades Holdings, underscoring confidence in CompanyCam’s durable growth and vision to transform how contractors work

LINCOLN, Neb., Aug. 21, 2025 — CompanyCam, the leading job site productivity platform with field-ready AI, today announced a new strategic growth investment from B Capital through its Series C transaction. B Capital, now CompanyCam’s largest external investor, and Decades Holdings join a distinguished group of top-tier growth investors, including Insight Partners, JMI Equity, Blueprint Equity, Nelnet, Invest Nebraska, and WndrCo.

CompanyCam’s platform replaces messy text threads, scattered paper notes, and manual photo storage with a single, real-time source of truth for every job site. Crews can capture and share project updates instantly in any language, keeping teams aligned, customers informed, and work moving forward without delays or miscommunications. This approach has made CompanyCam a trusted partner to tens of thousands of contracting businesses that depend on it to keep projects on track and communication clear.

B Capital’s significant investment reflects continued confidence in CompanyCam’s category leadership and long-term vision to transform the construction industry through its AI-powered industrial work operating system, enabling contractors to do good work, acquire the right customers, and get paid fast. 

With durable ARR growth and a profitable track record, CompanyCam is poised to expand its leadership in construction technology and continue to embed AI into every workflow, deepen integrations with contractors’ existing tools, and scale its presence globally.

“We are thrilled to partner with B Capital – a firm that understands the workday realities of our contractors and brings deep expertise in AI and unique AI engineering capabilities,” said Luke Hansen, CEO of CompanyCam. “We share the conviction that AI will revolutionize field work and deliver the results our customers want: fewer errors, increased revenue, and most importantly, more time spent with their families.”

“With its loyal customer base of tradesmen and contractors across the country, CompanyCam has the perfect foundation to introduce more practical, time-saving AI tools to its customers. As a value-added strategic growth investor with unique AI engineering capabilities, B Capital is excited to help accelerate product development and the company’s evolution into an AI-first solution for tradesmen,” said Timur Akazhanov, General Partner at B Capital. “We look forward to partnering with Luke and the entire CompanyCam team to build a category-defining business and to deliver valuable solutions for customers across the industry.”

William Blair served as CompanyCam’s financial advisor for the transaction.

About CompanyCam
CompanyCam is the leading job site productivity platform for contractors, helping them document jobs, communicate with crews, and share progress with clients in real time. Founded in 2015 in Lincoln, Nebraska, CompanyCam’s job site management tools and AI shortcuts are trusted by contractors at every phase of any project. Learn more at companycam.com.

About B Capital
B Capital invests globally in extraordinary founders and businesses shaping the future through technology. With more than $9 billion in assets under management and dedicated stage-based funds, the firm focuses on seed to early- and late-stage venture growth investments, primarily in the technology, healthcare, and resilience tech sectors. Founded in 2015, B Capital has an integrated, global team across nine locations in the U.S. and Asia. The firm’s value-add platform, together with the consulting expertise of its strategic partner, The Boston Consulting Group, provides entrepreneurs with the tools and resources to scale quickly and efficiently, expand into new markets, and build market-leading businesses. For more information, click here.

About Decades Holdings
Decades Holdings backs category-defining technology companies and is founded and led by David Zhang. For more information, click here.

SOURCE CompanyCam

NEW YORK, Aug. 21, 2025 — CVector Energy, the company building the data backbone for industrial AI, announced a $1.5 million pre-seed round led by Schematic Ventures. CVector is pioneering the infrastructure to unlock AI-native operations in factories and critical infrastructure—redefining how industrial systems sense, reason, and respond.

CVector’s time-series AI platform fuses ultra-high-fidelity asset data with dynamic external signals—like energy prices, weather, and market conditions—giving operators a unified system to power real-time decisions. Legacy data stacks weren’t designed for AI and rapidly changing market conditions. CVector is the essential first step toward an autonomous, AI-driven industrial future.

Built for the world’s most complex environments, CVector enables operators to plug in AI agents, run hybrid physics-informed models, and deploy self-healing troubleshooting capabilities. The platform learns from operator behavior and adapts to site-specific workflows—delivering tailored, actionable intelligence exactly when and where it’s needed.

Founded in November 2024 by engineers and researchers from Shell and CERN, CVector is already in use across energy, chemicals, and advanced manufacturing—powering insights from R&D labs to brownfield assets. The company achieved ISO 27001 certification in June 2025, with SOC 2 Type II in progress, underscoring its commitment to enterprise-grade security.

“CVector is building the brain and nervous system for industrial assets,” said Richard Zhang, co-founder and CEO. “We’re giving operators and engineers a foundation to plug in AI, understand system-wide behavior, and act with speed and precision. This round will help us bring that capability to even more mission-critical environments.”

CVector introduces hardened innovations from sectors like finance, oil & gas, and racing into the industrial world. Its adaptive AI layer goes beyond analytics—it captures long-term system patterns and operator habits to enable smarter troubleshooting, faster root-cause analysis, and more proactive system planning.

“We go far beyond data collection,” said Dr. Tyler Ruggles, co-founder and CTO. “With CVector, operators can run complex techno-economic modeling at the edge. It’s not just about insight—it’s about automated action and real operational lift.”

Julian Counihan, General Partner at Schematic Ventures, added: “CVector is solving one of the most fundamental gaps in industrial AI: making operational data truly usable. Their platform is purpose-built for factories and field environments. We believe CVector will be foundational infrastructure for the autonomous industrial systems of tomorrow.”

With headquarters in Providence, RI and offices in New York, NY, and Frankfurt, Germany, CVector is accelerating toward a future where industrial systems operate near-autonomously—guided by real-time intelligence, adaptive AI, and secure, self-healing control. The funding will go toward team expansion, product development, and scaling deployments in the world’s most demanding operational settings.

About CVector Energy

CVector Energy is a US-based software company building the data and intelligence backbone for industrial AI. Its platform connects high-fidelity machine data with external signals—like energy prices and weather—to enable real-time optimization, adaptive intelligence, and hybrid physics-informed modeling. Purpose-built for industrial operators, CVector helps teams troubleshoot, simulate, and optimize complex systems at the edge. For more, visit www.cvector.com.

About Schematic Ventures

Schematic Ventures is a venture capital firm focused on early-stage investments in supply chain, manufacturing, and industrial technologies. Schematic partners with technical founders building the next generation of operational infrastructure. Learn more at www.schematicventures.com.

Media Contact:
Richard Zhang
[email protected]
202-579-9478

SOURCE CVector

ATLANTA, Aug. 21, 2025 — Verdata, a leader in proprietary commercial risk data and analytics, announced today an $8 million Series A financing led by Continental Investors, with participation from 1st & Main Growth Partners, Front Porch Venture Partners, Overline Venture Capital, and several industry leaders.

Verdata delivers verified cross-industry insights on business identity, financial stability, service reliability, and regulatory compliance. Its proprietary network of more than 20 million active U.S. businesses enables objective, scalable risk assessments—reducing manual intervention, mitigating fraud and compliance risks, and unlocking new revenue opportunities.

“Verdata is redefining how trust is established in B2B relationships,” said CEO Mike Mondelli. “This funding accelerates product innovation, strengthens support for our customers, and extends our reach across key industries.”

Verdata helps clients:

• Verify business and principal identities to combat fraud
• Ensure brand alignment to manage regulatory risk
• Prioritize high-impact workflows
• Drive revenue growth with confidence

Its solutions are used in SMB lending, POS financing, commercial insurance, and embedded finance to manage relationship risk and build lasting partnerships.

“Team Continental is pleased to lead this round,” said Paul Purcell, Principal at Continental Investors. “Verdata’s collaborative approach aggregates fragmented commercial data into proprietary insights that improve customer acquisition, decision-making, and industry-wide efficiency.”

About Verdata

Verdata helps embedded finance providers, SMB lenders, payment processors, medical financiers, and banks build trust in B2B relationships. Our platform automates partner assessments and delivers continuous monitoring to reduce fraud, compliance, and regulatory risks across the entire relationship lifecycle.

SOURCE Verdata

Funding positions KROMATID for accelerated growth in genomic analysis and gene editing technologies

BOULDER, Colo., Aug. 20, 2025 — KROMATID, a leader in next-generation genomic structural analysis, today announced the successful close of its Series C funding round, raising a total of $8 million and surpassing its targeted capital goals. The most recent tranche of the round contributed $3.8 million. The round was led by BroadOak Capital Partners, with participation from both existing and new strategic investors.

The capital from this Series C close will fuel expansion of KROMATID’s proprietary platforms for detecting chromosomal structural rearrangements, scale operations to meet growing global demand, and advance strategic partnerships with pharmaceutical and academic leaders in cell and gene therapy.

“We are thrilled to have achieved our funding goal, which is a testament to the confidence our investors have in our vision and the unique capabilities of our technology,” said Jim Chomas, CEO of KROMATID. “This investment enables us to scale faster, innovate further, and continue delivering the genomic insights that help bring life-changing therapies to patients.”

“KROMATID has built a differentiated platform that provides accurate, high-resolution analysis of genomic integrity, one of the most pressing needs in the rapidly expanding gene and cell therapy industry,” said Bill Snider, Partner at BroadOak Capital Partners. “We are proud to continue our partnership as they enter their next phase of growth.”

Over the next 12–18 months, KROMATID plans to deploy this funding to accelerate commercial expansion and enhance automation and throughput in its laboratory operations. The company will also invest in strategic hiring across scientific, operational, and customer-facing teams to meet increasing market demand and solidify its leadership position in genomic structural analysis.

About KROMATID
KROMATID delivers next-generation genomic structural analysis solutions for gene and cell therapy developers, enabling precise detection of chromosomal structural rearrangements with unmatched clarity and resolution. By combining proprietary imaging and bioinformatics capabilities, KROMATID supports therapeutic innovation from discovery through regulatory approval.

About BroadOak Capital Partners
BroadOak Capital Partners is a boutique financial institution that provides direct investment and investment banking services to companies in the life science tools, diagnostics, and biopharma services sectors. BroadOak has invested in more than 70 life sciences companies including over 35 exits. For more information, visit www.broadoak.com.

Media Contact:
Amanda Ladas
Global Marketing Manager
KROMATID
[email protected]
773-720-0709

SOURCE KROMATID

• Funding will be used to establish the clinical utility of OneMap™, a proprietary artificial intelligence (AI) driven single cell transcriptomic oncology platform, to guide treatment decisions, patient selection, therapy development, and optimize clinical trials
• Proceeds will also help scale strategic partnerships with pharmaceutical and biotechnology companies
• Financing led by Redmile Group and Blast, with participation from Galion.exe, Invus, Adamed Technology, Sofinnova Partners, Polytechnique Ventures and Kima Ventures

PARIS, July 17, 2025 — One Biosciences (“One Biosciences” or the “Company”), a precision oncology techbio company pioneering clinical grade single-cell tumor transcriptomic profiling, today announced a €15 million Series A financing led by Redmile Group and Blast, with participation from Galion.exe, Invus, Adamed Technology, Sofinnova Partners, Polytechnique Ventures, and Kima Ventures. This round brings One Biosciences’ total funding, to date, to over €20 million including Home Biosciences’ seed financing.

One Biosciences technology creates detailed functional profiles of patient tumors, unlocking insights that may drive better clinical decision-making, patient selection, therapy development, and potentially optimizing clinical trials. Proceeds from the financing will accelerate the clinical development of One Biosciences’ flagship OneMap™ platform and support the scaling of strategic partnerships with pharmaceutical and biotech companies.

Hedi Ben Brahim, CEO of One Biosciences, said: “This funding enables us to translate our breakthrough single-cell technology into real-time insights that could directly inform physician decision-making, improve patient care, and accelerate drug development. The extraordinary support we have received from this group of leading global investors reinforces our conviction and fast-tracks our route to market.”

Dr. Céline Vallot, Co-Founder of One Biosciences and group leader at Curie Institute, commented: “This investment coupled with our established capacity to train our AI algorithms with proprietary single-cell patient datasets will further substantiate our ability to predict the response to most classes of oncology therapeutics from clinical grade specimens.” 

Dr Mehdi Touat, Assistant Professor, Assistance Publique – Hôpitaux de Paris AP-HP, Pitié-Salpêtrière and Paris Brain Institute, said: “Widespread use of next generation sequencing (NGS) profiling has led to substantial advances in cancer care but the clinical benefit remains limited to small patient subsets. We believe clinical grade single cell profiling has the potential to catalyze the next generation of diagnostic and therapeutic advances “.

About One Biosciences

One Biosciences, founded by Dr. Céline Vallot, Curie Institute and Home Biosciences in 2020, is an AI driven single cell transcriptomic oncology solutions company that is pioneering clinical grade single-cell tumor transcriptomic profiling. We aim to help clinicians select optimal treatments for their patients by decoding tumor heterogeneity from standard clinical samples, while enabling pharmaceutical companies to improve clinical trial outcomes. One Biosciences has partnerships with Curie Institute, Gustave Roussy Institute and AP-HP and is supported by Medicen, PSCC and Matwin. The company is financed by Bpifrance, Région Ile de France, France 2030, Redmile Group Blast, Galion.exe, Invus, Adamed Technology, Sofinnova Partners, Polytechnique Ventures and Kima Ventures.

For more information, visit: www.onebiosciences.fr

SOURCE One Biosciences

Funding commitment makes Veralto a Cornerstone Investor of the new proposed fund, expected to launch in October

WALTHAM, Mass., July 22, 2025 — Veralto Corporation (NYSE: VLTO) (the “Company”), a global leader in essential water and product quality solutions dedicated to Safeguarding the World’s Most Vital Resources™, announced a €20 million investment commitment in Emerald Technology Ventures’ Global Water Fund II, reinforcing the Company’s focus on driving the next wave of water innovation and advancing breakthrough technologies that address critical global water challenges.

Headquartered in Zurich with offices in Toronto and Singapore, Emerald is one of the first venture capital firms to focus on sustainable industrial innovation, with more than €1.2 billion in assets under management.

Veralto’s investment gives the Company visibility and access to key early- and growth-stage water technology businesses that address the most complex challenges facing Veralto’s current customers. The investment also offers Emerald’s portfolio companies an opportunity to benefit from the Company’s strong customer intimacy, global market reach, and track record of successfully scaling innovative businesses.

“Emerald’s global presence and deep sector expertise provide Veralto with early insight into emerging water-focused ventures, making it a strong strategic partner to augment our innovation and technology development efforts,” said Jennifer L. Honeycutt, President and Chief Executive Officer at Veralto. “This move strengthens our ability to identify and scale solutions that align closely with our customers’ needs in addressing critical water challenges worldwide.”

“Veralto, as a leading global player in water analytics and treatment, is a natural partner for our next Global Water Fund,” said Dr. Helge Daebel, Partner and Head of Emerald’s Water Practice. “Their purpose aligns with our more than 25 years of investing in sustainable industrial transformation, and they will join the ranks of more than 50 large corporations that we already count as investors and partners in our open innovation efforts.”

Emerald’s €150-180 million Global Water Fund II, which will launch in October, is designed to accelerate innovation across the water value chain, including technologies that address treatment, monitoring and emerging contaminants. The new partnership reflects a shared mission to shape the future of water through innovation and collaboration.

ABOUT VERALTO
With annual sales of over $5 billion, Veralto is a global leader in essential technology solutions with a proven track record of solving some of the most complex challenges we face as a society. Our industry-leading companies with globally recognized brands help billions of people around the world access clean water, safe food and trusted essential goods. Headquartered in Waltham, Massachusetts, our global team of nearly 17,000 associates is committed to making an enduring positive impact on our world and united by a powerful purpose: Safeguarding the World’s Most Vital Resources™.

ABOUT EMERALD TECHNOLOGY VENTURES
Emerald is a globally recognized venture capital firm, founded in 2000, that manages and advises assets of over €1 billion from its offices in Zurich, Toronto and Singapore. The firm invests in start-ups that tackle big challenges in climate change and sustainability, with four current funds, hundreds of venture transactions and five third-party investment mandates, including loan guarantees to over 100 start-ups.

FORWARD-LOOKING STATEMENTS
Certain statements in this release, including the statements regarding Emerald Technology Ventures and its Water Fund, the Company’s differentiation and positioning to continue delivering sustainable, long-term shareholder value and any other statements regarding events or developments that we believe or anticipate will or may occur in the future are “forward-looking” statements within the meaning of the federal securities laws. All statements other than historical factual information are forward-looking statements, including, without limitation, statements regarding: projections of revenue, expenses, profit, profit margins, asset values, pricing, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, Veralto’s liquidity position or other financial measures; Veralto’s management’s plans and strategies for future operations, including statements relating to anticipated operating performance, customer demand, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions and the integration thereof, divestitures, spin-offs, split-offs, initial public offerings, other securities offerings or other distributions, strategic opportunities, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets Veralto sells into, including the impact of changes to global trade policies, restrictions on imports, related countermeasures and reciprocal tariffs; future, new or modified laws, regulations, accounting pronouncements or public policy changes; regulatory approvals and the timing and conditionality thereof; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; future foreign currency exchange rates and fluctuations in those rates; results of operations and/or financial condition; general economic and capital markets conditions; the anticipated timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that Veralto intends or believes will or may occur in the future. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings. These forward-looking statements speak only as of the date of this release and except to the extent required by applicable law, the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

SOURCE Veralto

In addition to the €10 million in non-dilutive financing obtained by Stellaria through its success in the France 2030 ‘Innovative Reactors’ call for projects, this funding will be used to finance all the technical and regulatory studies necessary to establish a first molten-salt facility capable of sustaining a fission reaction, scheduled for 2029.

Founded in 2023, Stellaria is developing the Stellarium, a fourth-generation molten-salt nuclear reactor capable of fully regenerating its fuel during operation. It will therefore be self-sufficient for more than 20 years, while reducing long-lived nuclear waste (minor actinides). The first production unit is expected to be offered for commercial deployment by 2035. Competitive, safe and flexible, the Stellarium will also help to decarbonise energy production, whether for industry or the grid. By replacing fossil fuel sources with Stellarium, it will be possible to cut CO2 and particulate emissions from industrial sites by 99%.

Thanks to this funding, Stellaria aims to double its workforce to accelerate R&D around its reactor and finalise the development of one of the world’s first liquid-core fast-neutron reactor demonstrators. This step will allow it to develop its research laboratory in Grenoble by several million euros, to continue its scientific and industrial collaborations, and submit an Application for Authorisation to Create (DAC) a Basic Nuclear Installation (INB) to the safety authorities for the construction of its prototype.

Nicolas Breyton, CEO of Stellaria, said: “This funding round demonstrates the confidence of investors in the technical maturity of our molten-salt reactor, which opens up a new path towards the circular economy of the fuel cycle. We are laying the foundations for a model in which electro-intensive industries become self-sufficient in energy throughout the lifetime of their facilities. This is a key step towards the sustainable reindustrialisation of our territory.”

PDF: https://mma.prnewswire.com/media/2737585/Stellaria_Nuclear_Reactor.pdf
Logo: https://mma.prnewswire.com/media/2737584/Stellaria_Logo.jpg 

Press contact:
Comclean
Anna Denysova
[email protected]

SOURCE Stellaria

Pioneering Growth and Innovation in the Frozen Novelty Category

LONDON, Aug. 4, 2025 — Doughlicious®, the better-for-you frozen novelty brand known for its artisanal frozen cookie dough-enrobed gelato bites, indulgent flavors, and clean ingredients is thrilled to announce a major milestone in its journey: a $5 million fundraise round led by Rich Products Ventures (RPV), the corporate venture capital fund of global, family-owned food company Rich Products (Rich’s), and private investor collective The Angel Group, along with participation from existing investors.

This exciting fundraise marks a pivotal moment for Doughlicious as it accelerates its expansion across the U.S. and international markets. With a long track record of helping innovative food startups scale, gain a competitive edge and achieve their full potential, RPV brings deep category expertise and global distribution support. The Angel Group, a network of visionary investors with a passion for disruptive consumer brands, brings strategic counsel, access to influential networks, and a shared commitment to long-term growth.

“This partnership with Rich’s and The Angel Group is more than an investment—it’s a vote of confidence in the future of Doughlicious and our mission to redefine indulgence,” said Kathryn Bricken, Founder and CEO of Doughlicious. “With their support, we’re poised to grow faster, innovate smarter, and bring our crave-worthy creations to more consumers around the world.”

Doughlicious has already made a strong mark in retail, with distribution in major U.S. retailers including Target, Whole Foods, Wegmans, and GoPuff. The brand’s line of frozen gelato bites wrapped in cookie dough and dusted in cookie crumb are gluten-free, made with natural ingredients, and available in both full-size and mini formats, offering a modern twist on nostalgic favorites.

“Innovation is at the core of both Rich’s and RPV, and we believe in the bold ideas that are shaping the future of food,” said Dinsh Guzdar, managing partner of Rich Products Ventures. Doughlicious is a great example of a brand that is delivering on what today’s consumers want – smaller portions and clean-label offerings that don’t sacrifice on taste. We’re excited to help Doughlicious expand its footprint throughout the U.S. and shake up the freezer section with a new concept in permissible indulgence.”

Together, this dynamic trio—Doughlicious, Rich’s, and The Angel Group—are baking up something truly special. With innovation, passion, and strategic resources in the mix, Doughlicious is ready to take the frozen novelty dessert world by storm.

About Doughlicious The London Dough Co.:

Doughlicious is a proudly female-founded and operated business on a mission to redefine the cookie dough experience by creating the ultimate snackable treat. Focused on better-for-you ingredients and sustainable practices, the brand brings a fresh perspective to the frozen snack category. Doughlicious’ frozen cookie dough & gelato bites are certified gluten-free, free from added refined sugars and white bleached flour, and contain no artificial additives or preservatives. All frozen snacks are carefully crafted and produced at the brand’s facility in London, England. Doughlicious products are available in over 10,000 retail stores across the US, UK, parts of Europe and the Middle East. For more information, visit https://doughlicious.co.uk/, Instagram and TikTok.

Meet Rich’s:

Rich’s, also known as Rich Products Corporation, is a family-owned food company dedicated to inspiring possibilities. From cakes and icings to pizza, appetizers and specialty toppings, their products are used in homes, restaurants and bakeries around the world. Beyond great food, their customers also gain insights to help them stay competitive, no matter their size. Their portfolio includes creative solutions geared at helping food industry professionals compete in foodservice, retail, in-store bakery, deli, and prepared foods, among others. Working across 100 locations globally, with annual sales exceeding $5.8 billion, Rich’s is a global leader with a focus on everything that family makes possible. Rich’s®—Infinite Possibilities. One Family.

Rich Products Ventures (RPV) is the corporate venture capital arm of Rich Products. RPV invests in venture and growth stage companies that are shaping the future of food through technology and innovation, focusing on four core areas: nutrition and health, sustainable production, the next generation of retail and foodservice and dynamic supply chain. Offering a mix of operational expertise, strategic relationships, flexible capital and global reach, RPV helps startups scale, gain a competitive edge and achieve their full potential.

Learn more at www.Richs.com and www.richproductsventures.com or join the conversation on Facebook, Instagram, LinkedIn and Twitter.

Media Contacts: 
Whitney Spielfogel, Doughlicious
516-316-4201
[email protected]

Allie Friedman, Rich Products / Rich Products Ventures
716-479-3969
[email protected]

SOURCE Doughlicious®

The funding will fast-track EDGX’s mission to deliver the world’s fastest AI-powered edge computers for satellite constellations, enabling fast and efficient data processing from space

GHENT, Belgium, Aug. 11, 2025 — Belgian spacetech startup EDGX has closed a €2.3 million seed funding round to accelerate commercialisation of EDGX Sterna, the next generation edge AI computer for satellites.

The startup has also closed a multi-unit deal with a satellite operator worth €1.1 million and can already announce plans of an in-orbit demonstration on a SpaceX Falcon 9 mission in February 2026.

The funding round was co-led by the imec.istart future fund and, with participation from the Flanders Future Tech Fund, managed by the Flemish investment company PMV. EDGX has also attracted further funding from existing investor imec.istart, Europe’s top-ranked university-affiliated accelerator.

The EDGX Sterna Computer is a high-performance data processing unit (DPU) powered by NVIDIA technology. It provides the computational performance and AI acceleration needed to run complex algorithms directly in orbit. This capability eliminates the traditional bottleneck of sending massive raw datasets to Earth for processing, enabling satellite operators to deliver faster, more efficient, and data-driven services.

EDGX’s Sterna computer is powered by its SpaceFeather software stack, built for autonomous, resilient, and upgradeable satellite operations. It includes a space-hardened Linux OS with full traceability, a dedicated supervisory system for autonomous health monitoring, radiation fault detection and recovery, and an in-orbit application framework for deploying new capabilities post-launch.

Commenting on the news, Nick Destrycker, founder and CEO said: “Customers aren’t waiting for flight validation, they’re signing now. With a full launch manifest, secured commercial contracts, and our first mission set for Falcon 9, this funding enables us to scale to meet demand for real-time intelligence from space.”

Kris Vandenberk, managing partner at imec.istart future fund said: “EDGX represents exactly the kind of transformative infrastructure play we look for. The space industry is hitting a fundamental bottleneck; we’re generating massive amounts of data in orbit but still using outdated ‘store and forward’ architectures. EDGX is solving this by bringing AI-powered edge computing directly into space, enabling satellites to analyse and act on data in real-time rather than waiting for ground processing.”

Photo – https://mma.prnewswire.com/media/2746931/EDGX.jpg
Logo – https://mma.prnewswire.com/media/2746930/EDGX_Logo.jpg

SOURCE EDGX